Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-20-032628

CEO acquired 6,172 shares (option exercise)

  • CEO gave up 1,108 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

PIMSTONE SIMON N. · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-26 Exercise or conversion : show line 1 in the form +6,172 $3.56 $21,972 264,294 D
2020-05-26 Shares withheld for taxes : show line 2 in the form −1,108 $14.90 $16,509 263,186 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-26 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −6,172 0 D
Loading xslF345X03/doc4.xml…